Eliem Therapeutics funding
Eliem Therapeutics funding profile: $80M total raised. Latest round: Series A. Backed by RA Capital Management, Access Biotechnology, Intermediate Capital Group.
Headquarters: Seattle, United States
Investors
- RA Capital Management
- Access Biotechnology
- Intermediate Capital Group
Fundraising guides
Browse the company funding database · Browse investors · Fundraising library
